Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)

Overview of attention for article published in Circulation Journal, June 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 66 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 34 publications that cite this research output.

34

The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.

Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients

Article in Clinical Therapeutics (October 2023)

Protocol for systematic review and meta-analysis on randomized clinical trials for direct oral anticoagulant in subjects with acute coronary syndrome

Article in Pharmacy Practice (June 2023)

Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications

Article in Expert Review of Clinical Pharmacology (December 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.